Key result
A 1-year change in left ventricular mass index predicted long-term outcomes in patients with chronic heart failure, with an adjusted hazard ratio of 1.21 per 10% increase for death or cardiovascular hospitalization.
Why the study?
Surveillance imaging is frequently used to detect cardiac remodelling, but data evaluating these changes and their association with outcomes in chronic HF are limited.
Does cardiac remodelling assessed by serial CMR predict death or cardiovascular hospitalization in patients with chronic heart failure?
Cohort (n=262)
Yes
Does cardiac remodelling assessed by serial CMR predict death or cardiovascular hospitalization in patients with chronic heart failure?
Hazard Ratio: 1.21 (95% CI 1.02–1.44)
p-value: p=0.031
A 1-year change in LV mass index assessed by CMR, rather than change in LVEF, significantly predicts long-term death or cardiovascular hospitalization in patients with chronic heart failure.
May support serial LVMI monitoring for prognostication in chronic HF; hypothesis-generating for therapeutic targeting.
AIMS: Surveillance imaging is often used to detect remodelling, a change in cardiac geometry, and/or function; however, there are limited data in patients with chronic heart failure (HF). We sought to characterize cardiac remodelling in patients with chronic HF and evaluate its association with outcome. METHODS AND RESULTS: A prospective cohort of patients at risk for HF or with chronic HF underwent cardiac magnetic resonance (CMR) at baseline and 1 year. Ventricular function, volumes, mass, left atrial volume, global longitudinal strain, and myocardial scar were measured. The primary outcome was a composite of death or cardiovascular hospitalization up to 5 years from the 1 year scan. Cox regression was used to identify 1 year CMR predictors of outcome after adjusting for baseline risk. A total of 262 patients (median age 68 years, 57% males) including 96 at risk for HF, 97 with HF and preserved ejection fraction, and 69 with HF and reduced ejection fraction were included. In the patients with HF, 55 events were identified during follow-up. After adjustment for baseline clinical risk, Cox proportion hazard regressions only identified 1 year change in left ventricular (LV) mass index as a CMR predictor of outcome, adjusted hazard ratio 1.21 (1.02, 1.44) per 10% increase, P = 0.031. Cardiac remodelling defined as a 1 year change in LV mass index ≥15% was observed in 35% of patients with HF. Patients with adverse remodelling of LV mass index had more events on Kaplan-Meier analyses compared to those with no remodelling, log-rank P = 0.004 for overall cohort, P = 0.035 for heart failure with preserved ejection fraction and P = 0.035 for heart failure and reduced ejection fraction. CONCLUSIONS: Cardiac remodelling is common during serial CMR assessment of patients with chronic HF. Change in LV mass predicted long-term outcomes whereas change in left ventricular ejection fraction did not.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2021) conducted a cohort in Chronic heart failure (n=262). 1-year change in left ventricular mass index vs. No adverse remodelling was evaluated on Composite of death or cardiovascular hospitalization up to 5 years from the 1 year scan (HR 1.21, 95% CI 1.02-1.44, p=0.031). A 1-year change in left ventricular mass index predicted long-term outcomes in patients with chronic heart failure, with an adjusted hazard ratio of 1.21 per 10% increase for death or cardiovascular hospitalization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: